Year |
Citation |
Score |
2020 |
Pi H, Nguyen HT, Venter H, Boileau AR, Woolford L, Garg S, Page SW, Russell CC, Baker JR, McCluskey A, O'Donovan LA, Trott DJ, Ogunniyi AD. Activity of Robenidine Analog NCL195 in Combination With Outer Membrane Permeabilizers Against Gram-Negative Bacterial Pathogens and Impact on Systemic Gram-Positive Bacterial Infection in Mice. Frontiers in Microbiology. 11: 1556. PMID 32849325 DOI: 10.3389/Fmicb.2020.01556 |
0.361 |
|
2020 |
Polyak SW, Mowla R, Venter H. Measuring Small Molecule Binding to Escherichia coli AcrB by Surface Plasmon Resonance. Methods in Molecular Biology (Clifton, N.J.). 2089: 119-130. PMID 31773650 DOI: 10.1007/978-1-0716-0163-1_7 |
0.395 |
|
2019 |
Wang Y, Alenzy R, Song D, Liu X, Teng Y, Mowla R, Ma Y, Polyak SW, Venter H, Ma S. Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors. European Journal of Medicinal Chemistry. 111910. PMID 31801655 DOI: 10.1016/J.Ejmech.2019.111910 |
0.405 |
|
2019 |
Khazandi M, Pi H, Chan WY, Ogunniyi AD, Sim JXF, Venter H, Garg S, Page SW, Hill PB, McCluskey A, Trott DJ. Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens. Frontiers in Microbiology. 10: 837. PMID 31105656 DOI: 10.3389/Fmicb.2019.00837 |
0.353 |
|
2019 |
Venter H. Reversing Resistance to Counter Antimicrobial Resistance in the World Health Organisation's Critical Priority of Most Dangerous Pathogens. Bioscience Reports. PMID 30910848 DOI: 10.1042/Bsr20180474 |
0.36 |
|
2019 |
Jin C, Alenazy R, Wang Y, Mowla R, Qin Y, Tan JQE, Modi ND, Gu X, Polyak SW, Venter H, Ma S. Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance. Bioorganic & Medicinal Chemistry Letters. PMID 30755336 DOI: 10.1016/J.Bmcl.2019.02.003 |
0.323 |
|
2018 |
Bi F, Song D, Zhang N, Liu Z, Gu X, Hu C, Cai X, Venter H, Ma S. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators. European Journal of Medicinal Chemistry. 159: 90-103. PMID 30268826 DOI: 10.1016/J.Ejmech.2018.09.053 |
0.37 |
|
2018 |
Liu J, Ma R, Bi F, Zhang F, Hu C, Venter H, Semple SJ, Ma S. Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine. Bioorganic & Medicinal Chemistry Letters. PMID 29657101 DOI: 10.1016/J.Bmcl.2018.04.015 |
0.323 |
|
2018 |
Bi F, Ji S, Venter H, Liu J, Semple SJ, Ma S. Substitution of terminal amide with 1H-1,2,3-triazole: Identification of unexpected class of potent antibacterial agents. Bioorganic & Medicinal Chemistry Letters. PMID 29433923 DOI: 10.1016/J.Bmcl.2018.02.001 |
0.313 |
|
2017 |
Wang Y, Mowla R, Ji S, Guo L, De Barros Lopes MA, Jin C, Song D, Ma S, Venter H. Design, synthesis and biological activity evaluation of novel 4-subtituted 2-naphthamide derivatives as AcrB inhibitors. European Journal of Medicinal Chemistry. 143: 699-709. PMID 29220791 DOI: 10.1016/J.Ejmech.2017.11.102 |
0.328 |
|
2017 |
Mowla R, Wang Y, Ma S, Venter H. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance. Biochimica Et Biophysica Acta. PMID 28890187 DOI: 10.1016/J.Bbamem.2017.08.024 |
0.356 |
|
2017 |
Ogunniyi AD, Khazandi M, Stevens AJ, Sims SK, Page SW, Garg S, Venter H, Powell A, White K, Petrovski KR, Laven-Law G, Tótoli EG, Salgado HR, Pi H, Coombs GW, et al. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent. Plos One. 12: e0183457. PMID 28873428 DOI: 10.1371/Journal.Pone.0183457 |
0.385 |
|
2017 |
Arzanlou M, Chai WC, Venter H. Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria. Essays in Biochemistry. 61: 49-59. PMID 28258229 DOI: 10.1042/Ebc20160063 |
0.338 |
|
2017 |
Venter H, Henningsen ML, Begg SL. Antimicrobial resistance in healthcare, agriculture and the environment: the biochemistry behind the headlines. Essays in Biochemistry. 61: 1-10. PMID 28258225 DOI: 10.1042/Ebc20160053 |
0.314 |
|
2017 |
Wang Y, Mowla R, Guo L, Ogunniyi AD, Rahman T, De Barros Lopes MA, Ma S, Venter H. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance. Bioorganic & Medicinal Chemistry Letters. PMID 28129976 DOI: 10.1016/J.Bmcl.2017.01.042 |
0.407 |
|
2017 |
Bi F, Guo L, Wang Y, Venter H, Semple SJ, Liu F, Ma S. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition. Bioorganic & Medicinal Chemistry Letters. PMID 28082038 DOI: 10.1016/J.Bmcl.2016.12.081 |
0.33 |
|
2016 |
Yan M, Ma R, Jia L, Venter H, Ma S. Synthesis and antibacterial activity of novel 3-O-descladinosylazithromycin derivatives. European Journal of Medicinal Chemistry. PMID 27836198 DOI: 10.1016/J.Ejmech.2016.10.065 |
0.308 |
|
2016 |
Seyedmohammad S, Fuentealba NA, Marriott RA, Goetze TA, Edwardson JM, Barrera NP, Venter H. Structural model of FeoB, the iron transporter from Pseudomonas aeruginosa, predicts a cysteine lined, GTP-gated pore. Bioscience Reports. 36. PMID 26934982 DOI: 10.1042/Bsr20160046 |
0.366 |
|
2015 |
Wang Y, Venter H, Ma S. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria. Current Drug Targets. PMID 26424403 DOI: 10.2174/1389450116666151001103948 |
0.379 |
|
2015 |
Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Frontiers in Microbiology. 6: 377. PMID 25972857 DOI: 10.3389/Fmicb.2015.00377 |
0.425 |
|
2014 |
Seyedmohammad S, Born D, Venter H. Expression, purification and functional reconstitution of FeoB, the ferrous iron transporter from Pseudomonas aeruginosa. Protein Expression and Purification. 101: 138-45. PMID 24993789 DOI: 10.1016/J.Pep.2014.06.012 |
0.413 |
|
2014 |
Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, Venter H, Chiu W, Luisi BF. Structure of the AcrAB-TolC multidrug efflux pump. Nature. 509: 512-5. PMID 24747401 DOI: 10.1038/Nature13205 |
0.473 |
|
2012 |
Ohene-Agyei T, Lea JD, Venter H. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets Fems Microbiology Letters. 333: 20-27. PMID 22568688 DOI: 10.1111/J.1574-6968.2012.02594.X |
0.436 |
|
2010 |
Welch A, Awah CU, Jing S, Van Veen HW, Venter H. Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa Biochemical Journal. 430: 355-364. PMID 20583998 DOI: 10.1042/Bj20091860 |
0.486 |
|
2009 |
Velamakanni S, Lau CH, Gutmann DA, Venter H, Barrera NP, Seeger MA, Woebking B, Matak-Vinkovic D, Balakrishnan L, Yao Y, U EC, Shilling RA, Robinson CV, Thorn P, van Veen HW. A multidrug ABC transporter with a taste for salt. Plos One. 4: e6137. PMID 19593434 DOI: 10.1371/Journal.Pone.0006137 |
0.447 |
|
2009 |
Barrera NP, Isaacson SC, Zhou M, Bavro VN, Welch A, Schaedler TA, Seeger MA, Miguel RN, Korkhov VM, van Veen HW, Venter H, Walmsley AR, Tate CG, Robinson CV. Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions. Nature Methods. 6: 585-7. PMID 19578383 DOI: 10.1038/Nmeth.1347 |
0.332 |
|
2008 |
Venter H, Velamakanni S, Balakrishnan L, van Veen HW. On the energy-dependence of Hoechst 33342 transport by the ABC transporter LmrA. Biochemical Pharmacology. 75: 866-74. PMID 18061142 DOI: 10.1016/J.Bcp.2007.10.022 |
0.443 |
|
2007 |
Bapna A, Federici L, Venter H, Velamakanni S, Luisi B, Fan TP, van Veen HW. Two proton translocation pathways in a secondary active multidrug transporter. Journal of Molecular Microbiology and Biotechnology. 12: 197-209. PMID 17587868 DOI: 10.1159/000099641 |
0.372 |
|
2006 |
Shilling RA, Venter H, Velamakanni S, Bapna A, Woebking B, Shahi S, van Veen HW. New light on multidrug binding by an ATP-binding-cassette transporter. Trends in Pharmacological Sciences. 27: 195-203. PMID 16545467 DOI: 10.1016/J.Tips.2006.02.008 |
0.428 |
|
2005 |
Venter H, Shahi S, Balakrishnan L, Velamakanni S, Bapna A, Woebking B, Veen HWv. Similarities between ATP-dependent and ion-coupled multidrug transporters. Biochemical Society Transactions. 33: 1008-1011. PMID 16246033 DOI: 10.1042/bst0331008 |
0.446 |
|
2005 |
Woebking B, Reuter G, Shilling RA, Velamakanni S, Shahi S, Venter H, Balakrishnan L, van Veen HW. Drug-lipid A interactions on the Escherichia coli ABC transporter MsbA. Journal of Bacteriology. 187: 6363-9. PMID 16159769 DOI: 10.1128/Jb.187.18.6363-6369.2005 |
0.455 |
|
2005 |
Shilling R, Federici L, Walas F, Venter H, Velamakanni S, Woebking B, Balakrishnan L, Luisi B, van Veen HW. A critical role of a carboxylate in proton conduction by the ATP-binding cassette multidrug transporter LmrA. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1698-700. PMID 16040836 DOI: 10.1096/Fj.04-3558Fje |
0.45 |
|
2005 |
Janvilisri T, Shahi S, Venter H, Balakrishnan L, van Veen HW. Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2). The Biochemical Journal. 385: 419-26. PMID 15362954 DOI: 10.1042/Bj20040791 |
0.414 |
|
2004 |
Xie H, Patching SG, Gallagher MP, Litherland GJ, Brough AR, Venter H, Yao SY, Ng AM, Young JD, Herbert RB, Henderson PJ, Baldwin SA. Purification and properties of the Escherichia coli nucleoside transporter NupG, a paradigm for a major facilitator transporter sub-family. Molecular Membrane Biology. 21: 323-36. PMID 15513740 DOI: 10.1080/09687860400003941 |
0.662 |
|
2004 |
Balakrishnan L, Venter H, Shilling RA, van Veen HW. Reversible transport by the ATP-binding cassette multidrug export pump LmrA: ATP synthesis at the expense of downhill ethidium uptake. The Journal of Biological Chemistry. 279: 11273-80. PMID 14660649 DOI: 10.1074/Jbc.M308494200 |
0.414 |
|
2003 |
Venter H, Shilling RA, Velamakanni S, Balakrishnan L, Van Veen HW. An ABC transporter with a secondary-active multidrug translocator domain. Nature. 426: 866-70. PMID 14685244 DOI: 10.1038/Nature02173 |
0.452 |
|
2003 |
Shilling RA, Balakrishnan L, Shahi S, Venter H, van Veen HW. A new dimer interface for an ABC transporter. International Journal of Antimicrobial Agents. 22: 200-4. PMID 13678821 DOI: 10.1016/S0924-8579(03)00212-7 |
0.393 |
|
2003 |
Reuter G, Janvilisri T, Venter H, Shahi S, Balakrishnan L, van Veen HW. The ATP binding cassette multidrug transporter LmrA and lipid transporter MsbA have overlapping substrate specificities. The Journal of Biological Chemistry. 278: 35193-8. PMID 12842882 DOI: 10.1074/Jbc.M306226200 |
0.453 |
|
2003 |
Janvilisri T, Venter H, Shahi S, Reuter G, Balakrishnan L, van Veen HW. Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. The Journal of Biological Chemistry. 278: 20645-51. PMID 12668685 DOI: 10.1074/Jbc.M301358200 |
0.449 |
|
2002 |
Venter H, Ashcroft AE, Keen JN, Henderson PJ, Herbert RB. Molecular dissection of membrane-transport proteins: mass spectrometry and sequence determination of the galactose-H+ symport protein, GalP, of Escherichia coli and quantitative assay of the incorporation of [ring-2-13C]histidine and (15)NH(3). The Biochemical Journal. 363: 243-52. PMID 11931651 DOI: 10.1042/Bj3630243 |
0.54 |
|
2000 |
Venter H, Herbert R, Spooner P, Watts A, Homans S, Aschroft A, Henderson P. Novel applications of physical techniques to investigate the structure of the galactose H+-symporter (GalP) Biochemical Society Transactions. 28: A89-A89. DOI: 10.1042/Bst028A089B |
0.496 |
|
1999 |
Ward A, O'Reilly J, Rutherford NG, Ferguson SM, Hoyle CK, Palmer SL, Clough JL, Venter H, Xie H, Litherland GJ, Martin GE, Wood JM, Roberts PE, Groves MA, Liang WJ, et al. Expression of prokaryotic membrane transport proteins in Escherichia coli. Biochemical Society Transactions. 27: 893-9. PMID 10830123 DOI: 10.1042/Bst0270893 |
0.66 |
|
1999 |
Venter H, Herbert RB, Spooner PJ, Watts A, Henderson PJ. Expression of isotopically labelled membrane transport proteins Biochemical Society Transactions. 27: A150-A150. DOI: 10.1042/Bst027A150 |
0.6 |
|
Show low-probability matches. |